• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2020 Fiscal Year Final Research Report

Analysis of T follicular helper cells and B regulatory cells in patients with asthma comorbid with rhinitis by HDM-mites SLIT

Research Project

  • PDF
Project/Area Number 18K08391
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 54020:Connective tissue disease and allergy-related
Research InstitutionSapporo Medical University

Principal Investigator

Shigehara Katsunori  札幌医科大学, 医学部, 研究員 (70381275)

Co-Investigator(Kenkyū-buntansha) 亀倉 隆太  札幌医科大学, 医学部, 講師 (70404697)
Project Period (FY) 2018-04-01 – 2021-03-31
Keywords濾胞ヘルパーT細胞 / 濾胞制御性T細胞 / 制御性T細胞 / 制御性B細胞 / ダニ特異的免疫グロブリン / ダニ抗原舌下免疫療法 / アレルギー性鼻炎合併気管支喘息
Outline of Final Research Achievements

We examined T follicular helper(Tfh) cells and B regulatory(Breg) cells in patients with atopic asthma comorbid with allergic rhinitis treated with house dust mite(HDM)-sublingual immunotherapy(SLIT). Eleven patients of 18 patients showed good response. Tfh2 cells gradually decreased after 3 month therapy, conversely, Tfh1 cells gradually increased. HDM-specific IgE was transiently elevated at 3 month therapy, however, after 3 month therapy gradually decreased, HDM-specific IgG4 gradually increased for 12 months.
Tfh2 cells showed significantly negative correlation with T follicular regulatory(Tfr) cells and T regulatory (Treg) cells after 6 month therapy in responder patients.Inhibition against Tfh2 cell by Tfr and Treg cells lead to reduced production of HDM-specific IgE, and consequently improve Th2 reaction in responder patients.

Free Research Field

アレルギー学 免疫学 呼吸器病学

Academic Significance and Societal Importance of the Research Achievements

ダニアレルゲン舌下免疫療法ではアレルギー反応が改善し、薬物治療の中止や減量が多数認められる。アレルギーを誘導したり、改善させる抗体は以前より知られている。最近、濾胞ヘルパーT細胞が多くの疾患で抗体産生を制御が明らかとなってきた。この濾胞ヘルパーT細胞が抗体産性を通してアレルギー疾患に関わる仕組みは、まだ十分に解明されていない。解明されれば今後のアレルギー疾患の治療に大いに貢献することが考えられる。

URL: 

Published: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi